Chinese biotech firm Therorna closes $42m Series A financing round

The funding will help Therorna to fuel the development of a new broad-spectrum Covid-19 vaccine. In picture, 3D medical animation still shot showing the structure of a coronavirus. Credit: https://www.scientificanimations.com / commons.wikimedia.org.